European biotech just enjoyed its most abundant quarter in nearly two years in a tentative sign of a renaissance in the sector. There were 46 deals in Q1 2023, the second biggest year for deals in the region on Mergermarket...more
The effects of the COVID-19 outbreak leave many Belgian enterprises in financial distress, or even, for some of them, at risk of insolvency. In order to help these enterprises navigate the crisis and prevent them from going...more
5/3/2020
/ Belgium ,
Coronavirus/COVID-19 ,
Debtors ,
Enforcement Actions ,
Financial Distress ,
Insolvency ,
Moratorium ,
Popular ,
Publicly-Traded Companies ,
Small and Medium-Sized Enterprises (SMEs) ,
Small Business